Abstract
B lymphocytes belong to the adaptive immune system and they are responsible for humoral responses. In recent years, it has been demonstrated the existence of B cells with regulatory capacity (Breg) in humans and mouse models. The regulatory function of these B cells is explained by the production of IL-10 and the reduction of IFN-γ, TNF-α and IL-17 secretion by CD4 + T cells; in addition, Breg cells promote the differentiation of T lymphocytes into a regulatory phenotype and induce the remission of autoimmune manifestations in different murine models. In humans, alterations in number and function of Breg cells have been reported in systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases. Therefore, it has been suggested that Breg cells have an important role in the immunopathology of autoimmune diseases and may be a potential target for future treatments.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
